Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Safety of probiotics
1School of Medicine Sciences, RMIT University, Melbourne, Australia. d.donohue@rmit.edu.au
Novel probiotic bacteria require rigorous safety and efficacy evaluations before product incorporation. Current assessment methods are insufficient, necessitating a reevaluation of safety testing for new probiotic strains.
Area of Science:
- Microbiology and Food Science
- Probiotic Research and Development
Background:
- Novel probiotic strains are continuously sought for innovative food and therapeutic products.
- Traditional food organisms are often deemed safe without robust scientific criteria.
- Existing evidence for probiotic safety and efficacy is largely anecdotal or based on limited research.
Purpose of the Study:
- To highlight the critical need for thorough safety and efficacy assessments of novel probiotic strains.
- To discuss the limitations of current safety evaluation methods for probiotics.
- To advocate for a reconsideration of safety assessment procedures for new bacterial strains in food and therapeutic products.
Main Methods:
- Review and synthesis of existing literature on probiotic safety and efficacy testing.
- Analysis of the challenges in comparing different probiotic studies due to non-standardized methodologies.
- Discussion of the inadequacy of conventional toxicology for probiotic safety assessment.
Main Results:
- Conflicting data often arises from the testing of numerous bacterial strains for probiotic potential.
- Lack of standardized dosing and formulation equivalence hinders inter-study comparisons.
- There is significant debate regarding appropriate safety testing protocols for novel probiotics.
Conclusions:
- Current safety assessment procedures for novel probiotics are inadequate and require significant revision.
- Ensuring new probiotic strains are at least as safe as conventional counterparts is paramount.
- A comprehensive reevaluation of safety assessment strategies is essential for the responsible development of probiotic products.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Treatment of Constipation-Predominant IBS
Prevention of Further Absorption of Poison
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

